Characteristics | Quartiles of dietary inflammatory index (n = 256) | P value3,4 | |||
---|---|---|---|---|---|
Q1 (n = 64) | Q2 (n = 64) | Q3 (n = 64) | Q4 (n = 64) | ||
DII | |||||
 Median | 0.53 | 1.71 | 2.67 | 3.75 |  |
 Minimum, maximum | −3.77, 1.14 | 1.19, 2.21 | 2.22, 3.13 | 3.13,5.46 |  |
Age | 64.1 ± 9.5a | 58.3 ± 11.5b | 61.5 ± 12.5ab | 55.6 ± 13.1b | < 0.001 |
Male (%) | 38 (59.4)2 | 34 (53.1) | 40 (62.5) | 41 (64.1) | 0.6 |
Weight (kg) | 67.2 ± 11.81 | 64.6 ± 9.8 | 68.1 ± 12.8 | 69.8 ± 14.0 | 0.11 |
BMI, kg/m2 | 25.3 ± 3.8 | 24.4 ± 2.9 | 25.4 ± 3.8 | 25.9 ± 4.2 | 0.16 |
CKD stage (%) | Â | Â | Â | Â | 0.38 |
 Stage 1 | 6 (9.4) | 6 (9.4) | 8 (12.5) | 7 (10.9) |  |
 Stage 2 | 10 (15.6) | 17 (26.6) | 11 (17.2) | 21 (32.8) |  |
 Stage 3a | 12 (18.8) | 13 (20.3) | 9 (14.1) | 7 (10.9) |  |
 Stage 3b | 19 (29.7) | 9 (14.1) | 16 (25.0) | 13 (20.3) |  |
 Stage 4 | 15 (23.4) | 16 (25.0) | 15 (23.4) | 10 (15.6) |  |
 Stage 5 | 2 (3.1) | 3 (4.7) | 5 (7.8) | 6 (9.4) |  |
eGFR, mL/min/1.73m2 | 47.6 ± 25.0 | 52.7 ± 26.4 | 48.9 ± 29.3 | 52.5 ± 28.8 | 0.63 |
SBP, mmHg5 | 129.7 ± 12.9 | 126.0 ± 13.2 | 128.3 ± 11.2 | 128.1 ± 13.4 | 0.46 |
DBP, mmHg5 | 77.5 ± 10.5 | 76.3 ± 10.6 | 77.6 ± 9.4 | 79.7 ± 9.3 | 0.29 |
Current diabetes, n (%) | 31 (48.4) | 25 (39.1) | 27 (42.2) | 24 (37.5) | 0.61 |
Fasting blood glucose, mg/dL | 120.5 ± 36.4 | 112.6 ± 35.2 | 115.1 ± 22.4 | 109.9 ± 26.4 | 0.25 |
Malnutrition (%)6 | 4 (6.3) | 16 (25.0) | 7 (10.9) | 4 (6.3) | < 0.01 |